BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » HIV

3 Bullet Thursday – Stem Cells for HIV, ESCs vs. iPSCs, and Twitter as a News Source

October 29, 2015 By Cade Hildreth (CEO) Leave a Comment

3 Bullet Thursday - Oct 29, 2015

Stay alert to the latest and greatest on stem cells.  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells.


 

1. Wow, the world’s first clinical trial to treat HIV patients using umbilical cord blood transplants is set to start in Spain. Plans for the trial were announced last week at a haematology conference in Valencia by Spain’s National Organisation of Transplants (ONT).

 

2. Talk about a controversial topic! A new study published in Nature Biotechnology announces embryonic stem cells and induced pluripotent stem cells to be “equal.” More specifically, the authors state, “We conclude that hESCs and hiPSCs are molecularly and functionally equivalent.”

 

3. In a July 2013 USA Today article, Rem Rieder discusses how Twitter is a news pipeline for more than 200 million active users, often ‘breaking’ news before it’s actually news. Want to know where to get your morning stem cell news? These are the top 15 accounts breaking stem cell news on Twitter.

 

Happy Thursday!

 


Want to get this fun weekly update?  Join below and we’ll keep you in the loop, starting next week.

Filed Under: Cord Blood, iPS Cells, Stem Cells Tagged With: 3 bullet thursday, cord blood, embryonic stem cells, HIV, induced pluripotent stem cells, stem cells, twitter

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.